The global cranial clamps market is anticipated to reach USD 319.30 million by 2026, registering a CAGR of 4.7% during the forecast period, according to a new report by Grand View Research, Inc. increasing incidence of road accidents along with the prevalence of brain tumors and Traumatic Brain Injuries (TBIs) is anticipated to boost the market growth.
As per the National Health Portal, India, the incidence of central nervous system (CNS) tumors is 5 to 10 per 100,000 population. According to the Centers for Disease Prevention and Control (CDC), in 2014, about 2.87 million TBI related Emergency Department Visits, Hospitalizations and Deaths (EDHD) in U.S.
Cranial clamps are used during c; otolaryngology or ear, throat, and nose procedures; and orthopedics or musculoskeletal system related surgeries for providing the rigid fixation to the neck and head. Cranial clamps enables patient immobilization and reduces the risk of soft tissue injuries during the micro procedures. Increasing prevalence of brain and CNS tumors and TBIs is expected to drive the growth of the cranial clamps market over the forecast period.
Increasing initiatives by the government and non-profitable organizations for spreading awareness and the treatment of neurological diseases are also projected to fuel the market growth. For instance, new model of care for neurological services was launched in Ireland by the director-general of Health Service Executive (HSE).
View detailed insights @ https://bit.ly/30b4ywE
Cranial Clamps Market Report Highlights
• Surgery segment dominated the cranial clamps market by application in 2018 owing to the usage as the first line of treatment for brain tumors coupled with increasing prevalence of CNS tumors
• Adult patient formed the largest segment in 2018, owing to increasing prevalence of spinal tumors and TBI
• Hospitals end user segment held the leading market share in 2018, owing to increasing number of neurosurgeries and rise in TBI-related emergency visits
• North America led the global cranial clamps market in 2018, owing to the increasing incidence of neurological disorders such as Idiopathic intracranial hypertension (IIH) along with the presence of favorable government policies
• Few of the key market players are Pro-med instruments GmbH, Integra LifeSciences Corporation, Allen Medical (Hill-rom), B. Braun, Micromar Ind e com, and Eschmann Holdings Ltd (Steris PLC)
Get Sample PDF Copy @ https://bit.ly/3EXVycV